The article discusses the relationship between aging, neurodegeneration, and brain rejuvenation. It highlights that aging affects all organs and is partly encoded in a blood-based signature. Factors in the circulation can modulate aging and rejuvenate organs, including the brain. The aging brain shows characteristic changes linked to neurodegeneration, such as amyloid plaques, neurofibrillary tangles, and Lewy bodies. These features vary between individuals and may be precursors to neurodegenerative diseases or products of normal aging. Protein abnormalities and inclusion bodies in the aging brain suggest defects in proteostasis, which may contribute to neurodegeneration. The brain's aging is influenced by immune cells and secreted communication factors, and understanding the immune response in aging remains a challenge. Animal models suggest that circulatory cues can influence brain aging and cognitive function. The overlap between aging and neurodegeneration is evident in the presence of age-related protein abnormalities and inclusion bodies in the brain. These structures, such as lipofuscin, may impair normal brain function. The brain's aging is also associated with increased levels of lysosomal proteins and enzymes, and abnormal endosomes, lysosomes, and autophagosomes. Genetic manipulation of autophagy-related pathways in mice has shown effects on protein accumulation and disease progression. Stress granules, which can form in response to cellular stress, may play a role in neurodegenerative diseases like Alzheimer's and frontotemporal dementia. The circulatory proteome of organismal aging is explored, with studies showing that factors in the blood may influence brain aging and neurodegeneration. The communicome, a subset of the proteome involved in intercellular communication, is linked to aging and neurodegeneration. Proteins such as chordin-like protein 1, pleiotrophin, TIMP1, and cystatin-C are associated with aging. Studies using plasma proteomics have identified protein signatures that characterize the prodromal stages of Alzheimer's disease and its progression. These findings suggest that proteins in the blood may serve as biomarkers for brain aging and neurodegeneration. Abnormal intercellular communication and inflammation are linked to aging and neurodegeneration. Immune factors such as CCL11 and B2M may contribute to a low-grade inflammation known as inflammageing. Inflammatory factors in the aging brain may originate from microglia and astrocytes, which adopt a senescent-associated secretory phenotype. Genetic studies have shown that variations in genes like TREM2 increase the risk of Alzheimer's disease. Brain rejuvenation and the manipulation of aging are explored through studies on heterochronic parabiosis, which involves the exchange of blood between young and old organisms. These studies suggest that young blood factors can improve cognitive function and brain health in old mice. Factors such as GDF-11 and GHRH may have potential as brain-rejuvenation factors. The article concludes thatThe article discusses the relationship between aging, neurodegeneration, and brain rejuvenation. It highlights that aging affects all organs and is partly encoded in a blood-based signature. Factors in the circulation can modulate aging and rejuvenate organs, including the brain. The aging brain shows characteristic changes linked to neurodegeneration, such as amyloid plaques, neurofibrillary tangles, and Lewy bodies. These features vary between individuals and may be precursors to neurodegenerative diseases or products of normal aging. Protein abnormalities and inclusion bodies in the aging brain suggest defects in proteostasis, which may contribute to neurodegeneration. The brain's aging is influenced by immune cells and secreted communication factors, and understanding the immune response in aging remains a challenge. Animal models suggest that circulatory cues can influence brain aging and cognitive function. The overlap between aging and neurodegeneration is evident in the presence of age-related protein abnormalities and inclusion bodies in the brain. These structures, such as lipofuscin, may impair normal brain function. The brain's aging is also associated with increased levels of lysosomal proteins and enzymes, and abnormal endosomes, lysosomes, and autophagosomes. Genetic manipulation of autophagy-related pathways in mice has shown effects on protein accumulation and disease progression. Stress granules, which can form in response to cellular stress, may play a role in neurodegenerative diseases like Alzheimer's and frontotemporal dementia. The circulatory proteome of organismal aging is explored, with studies showing that factors in the blood may influence brain aging and neurodegeneration. The communicome, a subset of the proteome involved in intercellular communication, is linked to aging and neurodegeneration. Proteins such as chordin-like protein 1, pleiotrophin, TIMP1, and cystatin-C are associated with aging. Studies using plasma proteomics have identified protein signatures that characterize the prodromal stages of Alzheimer's disease and its progression. These findings suggest that proteins in the blood may serve as biomarkers for brain aging and neurodegeneration. Abnormal intercellular communication and inflammation are linked to aging and neurodegeneration. Immune factors such as CCL11 and B2M may contribute to a low-grade inflammation known as inflammageing. Inflammatory factors in the aging brain may originate from microglia and astrocytes, which adopt a senescent-associated secretory phenotype. Genetic studies have shown that variations in genes like TREM2 increase the risk of Alzheimer's disease. Brain rejuvenation and the manipulation of aging are explored through studies on heterochronic parabiosis, which involves the exchange of blood between young and old organisms. These studies suggest that young blood factors can improve cognitive function and brain health in old mice. Factors such as GDF-11 and GHRH may have potential as brain-rejuvenation factors. The article concludes that